San Diego, USA, October 8, 2024 – Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, today announced the appointment of Frank Poschen, a pioneer in organizational change and dynamic talent leader, to its Board of Directors […] The post Vividion Therapeutics Appoints Frank Poschen to Board o...
